Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$155,867,152
-$840,265 QoQ
Shares Held
287,668
+8.9% QoQ
Ownership
0.671%
of shares outstanding
% of Portfolio
8.50%
of 13F equity value
Holder Rank
#28
of 870 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$6,791,202
PutShares
16,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $209,186,993 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (74.5% of the industry book) .
All Filings in UTHR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,867,152 | 287,668 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $156,707,417 | 264,271 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $123,075,452 | 252,592 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $106,152,356 | 253,220 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $6,791,202 | 16,200 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $17,058,820 | 59,366 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,722,134 | 57,489 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,420,166 | 43,703 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $46,925,574 | 130,949 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $74,971,061 | 235,351 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $57,690,732 | 251,135 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $54,144,394 | 246,234 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $60,511,250 | 267,903 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,482,858 | 260,398 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $49,743,083 | 222,107 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $64,735,736 | 232,787 | Shares | Sole | 2023-11-08 | |
| 2022-09-30 | $53,439,219 | 255,226 | Shares | Sole | 2023-11-08 | |
| 2022-06-30 | $73,244,923 | 310,834 | Shares | Sole | 2023-11-08 | |
| 2022-03-31 | $52,429,701 | 292,234 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $1,642,208 | 7,600 | Call | Sole | 2023-11-08 | |
| 2021-12-31 | $84,686,073 | 391,920 | Shares | Sole | 2023-11-08 | |
| 2021-09-30 | $82,040,457 | 444,471 | Shares | Sole | 2023-11-08 | |
| 2021-06-30 | $79,468,762 | 442,945 | Shares | Sole | 2023-11-08 | |
| 2021-03-31 | $81,381,705 | 486,529 | Shares | Sole | 2023-11-08 | |
| 2020-12-31 | $69,616,358 | 458,636 | Shares | Sole | 2023-11-08 | |
| 2020-09-30 | $24,331,304 | 240,904 | Shares | Sole | 2023-11-08 | |
| 2020-06-30 | $28,153,796 | 232,676 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||